Stiglitz says no to TPP health tradeoffs in New York Times

January 30, 2015 Nobel Prize-winning economist Joseph Stiglitz warns in the New York Times that US proposals at ongoing TPP talks  would strengthen monopoly rights for pharmaceutical companies to delay cheaper generic medicines, and would undermine  government  regulation of drug prices..He warns that if these proposals are accepted in the TPP, they may become the new global standard, and the whole world may come to pay a price in the form of higher medicine prices,worse health and unnecessary deaths.

Send a message  today to the Australian Trade Minister to say not to these and other harmful proposals in the TPP!